Lisa F P Ng Selected Research

Neutralizing Antibodies

1/2024	Author Correction: Higher Delta variant-specific neutralizing antibodies prevented infection in close contacts vaccinated with ancestral mRNA vaccines during the SARS-CoV-2 Delta wave.
12/2023	Employment of a high throughput functional assay to define the critical factors that influence vaccine induced cross-variant neutralizing antibodies for SARS-CoV-2.
11/2023	Higher Delta variant-specific neutralizing antibodies prevented infection in close contacts vaccinated with ancestral mRNA vaccines during the SARS-CoV-2 Delta wave.
1/2020	Serological Approaches for COVID-19: Epidemiologic Perspective on Surveillance and Control.
1/2018	Plasmodium co-infection protects against chikungunya virus-induced pathologies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lisa F P Ng Research Topics

Disease

39	Infections 02/2024 - 01/2009
26	COVID-19 02/2024 - 01/2020
9	Inflammation (Inflammations) 01/2023 - 11/2011
6	Zika Virus Infection 10/2021 - 01/2017
6	Chikungunya Fever 01/2019 - 01/2009
6	Arthralgia (Joint Pain) 01/2018 - 01/2011
5	Alphavirus Infections 04/2021 - 10/2013
4	Viremia 01/2018 - 01/2011
4	Virus Diseases (Viral Diseases) 01/2018 - 01/2015
3	Disease Progression 01/2022 - 01/2018
2	Malaria 03/2024 - 01/2020
2	Breakthrough Infections 11/2023 - 06/2022
2	Pneumonia (Pneumonitis) 06/2022 - 01/2022
2	Acute Disease 01/2022 - 02/2015
2	Ebola Hemorrhagic Fever 11/2021 - 07/2017
2	Hypoxia (Hypoxemia) 09/2020 - 01/2020
2	Necrosis 10/2017 - 01/2017
2	Myositis (Idiopathic Inflammatory Myopathies) 10/2017 - 10/2013
2	Congenital Abnormalities (Deformity) 01/2017 - 01/2017
1	Carcinoma (Carcinomatosis) 04/2024
1	Viral Pneumonia 11/2021
1	Kidney Diseases (Kidney Disease) 01/2021
1	Convalescence 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Critical Illness (Critically Ill) 01/2021
1	Post-Acute COVID-19 Syndrome 01/2021
1	Respiratory Insufficiency (Respiratory Failure) 01/2021
1	Fever (Fevers) 09/2020
1	Coinfection 01/2020
1	Arbovirus Infections 01/2019
1	Liver Diseases (Liver Disease) 01/2018
1	Lymphopenia (Lymphocytopenia) 01/2018
1	Metabolic Diseases (Metabolic Disease) 01/2018
1	Cerebral Malaria 01/2018
1	Non-alcoholic Fatty Liver Disease 01/2018
1	Musculoskeletal Diseases (Musculoskeletal Disease) 10/2017

Drug/Important Bio-Agent (IBA)

19	VaccinesIBA 04/2024 - 12/2011
14	CytokinesIBA 01/2023 - 01/2009
12	Antiviral Agents (Antivirals)IBA 01/2023 - 05/2010
12	AntibodiesIBA 06/2022 - 04/2012
9	Proteins (Proteins, Gene)FDA Link 05/2023 - 12/2012
7	Immunoglobulin G (IgG)IBA 01/2022 - 04/2012
6	InterferonsIBA 02/2024 - 06/2015
5	Neutralizing AntibodiesIBA 01/2024 - 01/2018
5	Messenger RNA (mRNA)IBA 12/2023 - 10/2017
5	EpitopesIBA 01/2021 - 04/2012
4	mRNA VaccinesIBA 01/2024 - 01/2022
4	Immunoglobulin A (IgA)IBA 11/2023 - 01/2021
4	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2009
4	Immunoglobulin M (IgM)IBA 11/2021 - 12/2011
4	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2021 - 01/2011
4	Interleukin-6 (Interleukin 6)IBA 01/2018 - 01/2011
3	RNA (Ribonucleic Acid)IBA 01/2024 - 07/2017
3	COVID-19 VaccinesIBA 06/2022 - 01/2021
3	Peptides (Polypeptides)IBA 08/2020 - 04/2012
2	Interferon Type IIBA 01/2024 - 01/2022
2	Oxygen (Dioxygen)IBA 11/2021 - 01/2020
2	LigandsIBA 10/2021 - 10/2017
2	InterleukinsIBA 06/2021 - 04/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2021 - 01/2021
2	SARS-CoV-2 spike proteinIBA 01/2021 - 01/2020
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021 - 01/2009
2	Indicators and Reagents (Reagents)IBA 01/2020 - 06/2015
2	ChemokinesIBA 10/2017 - 01/2009
2	Interleukin-18 (Interleukin 18)IBA 10/2017 - 01/2017
2	PyrrolesIBA 01/2017 - 12/2015
2	Interleukin-2 (IL2)IBA 11/2016 - 06/2015
1	Peroxidase (Myeloperoxidase)IBA 05/2023
1	EnzymesIBA 05/2023
1	ImmunosorbentsIBA 05/2023
1	AutoantibodiesIBA 06/2022
1	BNT162 VaccineIBA 01/2022
1	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 06/2021
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 06/2021
1	Stem Cell FactorIBA 06/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	remdesivirIBA 01/2021
1	Viral ProteinsIBA 01/2021
1	Peptide LibraryIBA 08/2020
1	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 08/2020
1	Immunodominant EpitopesIBA 01/2020
1	Explosive Agents (Explosives)IBA 01/2020
1	Glycoproteins (Glycoprotein)IBA 01/2020
1	Interferon-gamma (Interferon, gamma)IBA 03/2018
1	Chloroquine (Aralen)FDA LinkGeneric 01/2018
1	Bile Acids and Salts (Bile Acids)IBA 01/2018
1	C-Reactive ProteinIBA 01/2018
1	CholesterolIBA 01/2018
1	LipidsIBA 01/2018
1	Viral RNAIBA 01/2018
1	Steroid 12-alpha-Hydroxylase (CYP8B1)IBA 01/2018
1	Interleukin-10 (Interleukin 10)IBA 01/2018
1	Interferon Regulatory Factor-1 (Interferon Regulatory Factor 1)IBA 01/2018
1	InflammasomesIBA 10/2017
1	N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA 10/2017
1	Nucleic AcidsIBA 07/2017

Therapy/Procedure

8	Therapeutics 01/2024 - 12/2011
3	Artificial Respiration (Mechanical Ventilation) 11/2021 - 09/2020
1	Drug Therapy (Chemotherapy) 01/2021
1	Immunotherapy 03/2018